Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
107.4 USD | +0.54% | +0.21% | -2.33% |
12:29am | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
12:21am | Edwards Lifesciences first-quarter profit beats estimates on heart devices strength | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.33% | 185B | |
-3.78% | 105B | |
-5.14% | 66.59B | |
+3.65% | 54.66B | |
+16.55% | 47.78B | |
+4.06% | 41.26B | |
+2.97% | 26.95B | |
+2.86% | 26.37B | |
+12.96% | 24.8B | |
-1.99% | 24.6B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Abbott Laboratories : JPMorgan Adjusts Price Target on Abbott Laboratories to $122 From $135, Maintains Overweight Rating